Keranova is a young and dynamic company specializing in the development of new-generation ophthalmic surgical devices. Their innovative technology harnesses the emerging science of photonics to create ultra-fast medical lasers. The flagship product, the FemtoMatrix® device, is a game-changer in the field of ophthalmic surgery, packed with 14 patented technological innovations that outperform existing surgical technology.

With the ability to modify the laser beam wavefront, the FemtoMatrix® is the only system capable of executing genuine cataract Photoemulsification®. Keranova's advancements are rooted in the groundbreaking work of the renowned academic laboratories at the Jean Monnet University of Saint Etienne in France. The FemtoMatrix® sets a new standard in surgical performance, offering unparalleled accuracy, automation, speed, and reproducibility.

By combining vision and intelligent software with exceptionally precise robotic movements, this automated equipment makes surgery safer and ensures equal opportunity for all patients. Keranova's mission is to contribute to the advancement of ophthalmic surgery, proposing new surgical devices and opening a new chapter in the field. With their innovative technology, they aim to provide access to a novel form of surgery that is faster, more accurate, and reproducible